Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 2, 2009, Pages 260-265

  Brossier, F ^a,b   Veziris, N ^a,b   Jarlier, V ^a,b   Sougakoff, Wladimir ^a,b,c,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Drug resistance; Isoniazid; Molecular diagnosis; Negative predictive value; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CODON; CONTROLLED STUDY; DRUG RESISTANT TUBERCULOSIS; FRANCE; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BIOLOGICAL ASSAY; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RIFAMPIN;

EID: 59549092659     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Edwards K J, Metherell L A, Yates M, Saunders N A. Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol 2001; 39: 3350-3352.
2. El-Hajj H H, Marras S A, Tyagi S, Kramer F R, Alland D. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001; 39: 4131-4137.
3. Park H, Song E J, Song E S, et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 1619-1624.
4. Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230.
5. Cardoso R F, Cooksey R C, Morlock G P, et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004; 48: 3373-3381.
6. Herrera-Leon L, Molina T, Saiz P, et al. New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2005; 49: 144-147.
7. Heym B, Zhang Y, Poulet S, Young D, Cole S T. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol 1993; 175: 4255-4259.
8. Lavender C, Globan M, Sievers A, Billman-Jacobe H, Fyfe J. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob Agents Chemother 2005; 49: 4068-4074.
9. Lei B, Wei C J, Tu S C. Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation and characterization of InhA inhibitor. J Biol Chem 2000; 275: 2520-2526.
10. Leung E T, Ho P L, Yuen K Y, et al. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob Agents Chemother 2006; 50: 1075-1078.
11. Sajduda A, Brzostek A, Poplawska M, et al. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 2004; 42: 2425-2431.
12. Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother 2003; 47: 2009-2011.
13. Kiepiela P, Bishop K S, Smith A N, Roux L, York D E Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa. Tuberc Lung Dis 2000; 80: 47-56.
14. Vilchèze C, Wang F, Arai M, et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 2006; 12: 1027-1029.
15. Zhang Y. Isoniazid. In: Rom W N, Garay S M, eds. Tuberculosis. 2nd ed. Philadelphia, PA, USA: Lippincott Williams and Wilkins, 2004: pp 739-758.
16. Vilchèze C, Jacobs W R Jr. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev Microbiol 2007; 61: 35-50.
17. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the Genotype® MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 2006; 44: 3659-3664.
18. Bang D, Bengård Andersen A, Thomsen V Ø. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006; 44: 2605-2608.
19. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 2338-2342.
20. Hillemann D, Rüsch-Gerdes S, Richter E. Application of the GenoType MTBDR assay directly on sputum specimens. Int J Tuberc Lung Dis 2006; 10: 1057-1059.
21. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43: 3699-3703.
22. Makinen J, Marttila H J, Marjamaki M, Viljanen M K, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 350-352.
23. Miotto P, Piana F, Penati V, Canducci F, Migliori G B, Cirillo D M. Use of GenoType MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006; 44: 2485-2491.
24. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smear-positive samples to assess the PCR-based GenoType MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 2006; 44: 4459-4463.
25. Canetti G, Rist N, Grosset J. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev Tuberc Pneumol (Paris) 1963; 27: 217-272.
26. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640.
27. Gali N, Dominguez J, Blanco S, et al. Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. J Clin Microbiol 2006; 44: 201-205.
28. Guo H, Seet Q, Denkin S, Parsons L, Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 2006; 55: 1527-1531.
29. Baker L V, Brown T J, Maxwell O, et al. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob Agents Chemother 2005; 49: 1455-1464.
30. Hazbón M H, Brimacombe M, Bobadilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006; 50: 2640-2649.
31. Zhang M, Yue J, Yang Y P, et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tubercu losis isolates from China. J Clin Microbiol 2005; 43: 5477-5482.
32. Miotto P, Piana F, Cirillo D M, Migliori G B. Genotype MTBDR plus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 46: 393-394.
33. Khuê P M, Truffot-Pernot C, Texier-Maugein J, Jarlier V, Robert J. A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-2004. Eur Respir J 2007; 30: 937-944.
34. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.